Teva/Novopharm
This article was originally published in The Tan Sheet
Executive Summary
Teva is in "advanced discussions" with Novopharm regarding its agreement to purchase the Canadian generic manufacturer. Teva, an Israeli pharmaceutical firm that does 80% of its business in the U.S. and Europe, says the deal will involve shares of its stock